NEW YORK (GenomeWeb) – Bioinformatics firm Insilico Medicine and Champions Oncology have announced they will expand an existing collaboration and work together to validate preliminary findings showing that molecular signatures of patients' tumor grafts in mice resemble the signatures in human patients before and after treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.